Showing 6601-6610 of 9228 results for "".
Sunscreen Ratings, Restylane Lyft for Hands, NPF, SCF News
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-sunscreen-ratings-restylane-lyft-for-hands-npf-scf-news/18305/Both Consumer Reports and the Environmental Working Group have issued sunscreen rankings, and while some products shine, many products may underperform. FDA issued warnings to several companies illegally marketing dietary supplements that make unproven drug claims about protecting consumers from sunSkin of Color Society in NYC; Highlights from 2017
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-skin-of-color-society-in-nyc-highlights-from-2017/18359/In this special edition of DermWireTV, Seemal Desai, MD offers a recap of the Skin of Color Society's media day in New York. Plus, a look at the most-read and viewed content from Practical Dermatology® magazine and DermTube.com, featuring Heidi Waldorf, MD, Linda Stein-Gold, MD, Ted Rosen, MD, JoelThe Viability of Phototherapy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-viability-of-phototherapy/18373/The excellent safety profile of phototherapy makes it a viable treatment option for many patients with psoriasis, even in an age of biologics, says Elma Baron, MD. Efficacy of phototherapy is high, she says.NRS: New Rosacea Classification; Pediatric Teledermatology; Bleach Baths
https://practicaldermatology.com/videos/dermwire-tv/nrs-new-rosacea-classification-pediatric-teledermatology-bleach-baths/18394/There's a new standard classification and pathophysiology of rosacea from the National Rosacea Society. New evidence shows that virtual diagnosis of pediatric dermatologic conditions is feasible. New research suggests that water baths may be just as good as bleach baths for treating eczema. ResearchBehind the Scenes: Preparing to Inject
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aad-orlando-daily-coverage-day---wvpotpwa/18529/Live injection sessions are a great way to learn techniques and review injection anatomy for best outcomes and patient safety. Doris Day, MD speaks about these issues and shares her perspective on preparing to inject for these sessions.Exploring the Complexities of Psoriasis
https://practicaldermatology.com/topics/psoriasis/exploring-the-complexities-of-psoriasis/18553/Biologic therapies developed over the last decade or more to treat psoriasis may do more than clear the skin. Researchers are investigating the effects of treatment on comorbid risks, and comparing treatment with older interventions. Jashin Wu, MD explains.All in One
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/all-in-one/18726/The Sciton Joule platform offers multiple treatment options to address multiple indications in a single, scalable system, making it a top laser platform pick for 2017, says Dr. Cohen during Cosmetic Surgery Forum.Pico Pick-up: Expanding Applications
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pico-pick-up-expanding-applications/18555/What started as a revolutionary approach to removing tattoos, is finding new applications for facial rejuvenation. The expanding use of picosecond technology is making the investment more attractive for aesthetically-focused practices, notes Dr. Gold.Differin Goes OTC, ISDIN Comes to America, Understand AD
https://practicaldermatology.com/topics/psoriasis/dermwiretv-differin-goes-otc-isdin-comes-to-america-understand-ad/18762/Barcelona-based ISDIN is officially operating in the US. The company—which operates in Europe, Latin America, and Asia—is bringing its skincare products to the US market. Regeneron Pharmaceuticals, Sanofi Genzyme, the National Eczema Association, and the Dermatology Nurses Association launch UnderBiosimilar Recommended; Saunders to Head New Pfizer/Allergan Organization
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-biosimilar-recommended-saunders-to-head-new-pfizer-allergan-organization/18825/An FDA committee has recommended Pfizer's Inflectra, biosimilar to infliximab, developed by Celltrion. Sunbelt Melanoma Trial finds no benefit for IFN in Phase III melanoma. Pfizer/Allergan provides details on structure of new organization and announces leadership, including President and COO Brent